These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 21160062)

  • 1. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?
    Tushuizen ME; Diamant M; Sturk A; Nieuwland R
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):4-9. PubMed ID: 21160062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The many faces of endothelial microparticles.
    Dignat-George F; Boulanger CM
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):27-33. PubMed ID: 21160065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte-derived microparticles in vascular homeostasis.
    Angelillo-Scherrer A
    Circ Res; 2012 Jan; 110(2):356-69. PubMed ID: 22267840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, cell differentiation, angiogenesis--microparticles and their roles in angiogenesis.
    Shai E; Varon D
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):10-4. PubMed ID: 21160063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microparticles: an introduction.
    Boulanger CM; Dignat-George F
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):2-3. PubMed ID: 21160061
    [No Abstract]   [Full Text] [Related]  

  • 6. Endothelial microparticles: missing link in endothelial dysfunction?
    Yong PJ; Koh CH; Shim WS
    Eur J Prev Cardiol; 2013 Jun; 20(3):496-512. PubMed ID: 22496273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular mechanisms underlying the formation of circulating microparticles.
    Morel O; Jesel L; Freyssinet JM; Toti F
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):15-26. PubMed ID: 21160064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microparticles: a component of various diseases.
    Budaj M; Poljak Z; Ďuriš I; Kaško M; Imrich R; Kopáni M; Maruščáková L; Hulín I
    Pol Arch Med Wewn; 2012; 122 Suppl 1():24-9. PubMed ID: 23222474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis.
    Leroyer AS; Anfosso F; Lacroix R; Sabatier F; Simoncini S; Njock SM; Jourde N; Brunet P; Camoin-Jau L; Sampol J; Dignat-George F
    Thromb Haemost; 2010 Sep; 104(3):456-63. PubMed ID: 20664896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases.
    Meziani F; Tesse A; Andriantsitohaina R
    Pharmacol Rep; 2008; 60(1):75-84. PubMed ID: 18276988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microparticles: targets and tools in cardiovascular disease.
    Martinez MC; Tual-Chalot S; Leonetti D; Andriantsitohaina R
    Trends Pharmacol Sci; 2011 Nov; 32(11):659-65. PubMed ID: 21794929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells.
    Burger D; Touyz RM
    J Am Soc Hypertens; 2012; 6(2):85-99. PubMed ID: 22321962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-derived microparticles in haemostasis and vascular medicine.
    Burnier L; Fontana P; Kwak BR; Angelillo-Scherrer A
    Thromb Haemost; 2009 Mar; 101(3):439-51. PubMed ID: 19277403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microparticles, vascular function, and atherothrombosis.
    Rautou PE; Vion AC; Amabile N; Chironi G; Simon A; Tedgui A; Boulanger CM
    Circ Res; 2011 Aug; 109(5):593-606. PubMed ID: 21852557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microparticles and cardiovascular disease].
    Morel O; Ohlmann P; Morel N; Jesel L; Bareiss P; Freyssinet JM; Toti F
    Arch Mal Coeur Vaiss; 2005 Mar; 98(3):226-35. PubMed ID: 15816326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microparticles: key protagonists in cardiovascular disorders.
    Amabile N; Rautou PE; Tedgui A; Boulanger CM
    Semin Thromb Hemost; 2010 Nov; 36(8):907-16. PubMed ID: 21069633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microparticles, vascular function and hypertension.
    Boulanger CM
    Curr Opin Nephrol Hypertens; 2010 Mar; 19(2):177-80. PubMed ID: 20051854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving role of microparticles in the pathophysiology of endothelial dysfunction.
    Lovren F; Verma S
    Clin Chem; 2013 Aug; 59(8):1166-74. PubMed ID: 23529703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cell-derived microparticules: key players at the crossroad between inflammation and thrombosis].
    Sabatier F; Lacroix R; Leroyer AS; Cointe S; Dignat-George F
    Transfus Clin Biol; 2011 Apr; 18(2):62-9. PubMed ID: 21444231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microparticles: A Pivotal Nexus in Vascular Homeostasis and Disease.
    McGinn CM; MacDonnell BF; Shan CX; Wallace R; Cummins PM; Murphy RP
    Curr Clin Pharmacol; 2016; 11(1):28-42. PubMed ID: 26725878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.